4 years ago

SleepCogni Secures £1.4 Million to Scale Insomnia Treatment

  • SleepCogni, a UK-based SleepTech startup, raised £1.4 million in debt and equity funding led by Chasnay Capital Partners, existing investors and retail investors

  • The company also received a loan from Innovate UK

  • This funding round values SleepCogni at £7.3 million

  • SleepCogni has developed a treatment for insomnia that uses a handheld medical device and platform to control the wind-down process

  • The company plans to use the funds to expand into the US market, prepare for volume manufacturing, develop its online platform, and achieve initial sales

  • SleepCogni has strengthened its executive team with Colin Greene, a former Apple executive, and Andrew Morfey, a former Finance Director at AXA Health-On-Line.

      • ProblemHealthcare

      "SleepCogni is addressing the issue of insomnia by providing a handheld medical device and platform to help users control their sleep process."

      Solution

      "The company offers a treatment that uses a device and platform to allow users to manage their insomnia effectively, showing promising results in clinical trials."

      Covered on